UH

Unihealth Hospitals Ltd

Q4 FY26Healthcare Services

Unihealth Hospitals Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹751
Market cap₹1.1K Cr
P/E41.9
Updated23 Aug 2026
Read4 min read

The short version

Unihealth expects 30% to 40% growth in the coming quarters due to a low baseline currently. Target EBITDA margins expected around mid-20% by 24 months post facility commissioning (Page 23).

From Unihealth Hospitals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Unihealth expects 30% to 40% growth in the coming quarters due to a low baseline currently.
  • By FY27, the company plans to operate about 600 beds consolidated across Uganda, Navi Mumbai, Nashik, and Tanzania, aiming to double revenues with an average revenue per occupied bed in the range of INR75 lakh to INR1 crore annually.
  • Target for operational bed capacity is over 420 beds currently, expected to cross 500 beds by year-end with ongoing expansions, including Tanzania and Nashik.
  • By calendar year-end 2028, Unihealth aims to have 1,000 commissioned beds with 55%-60% occupancy, targeting around INR1 to INR1.1 crore average revenue per occupied bed annually.

2 more points from Unihealth Hospitals Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Unihealth Hospitals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Unihealth plans capital expenditure (Capex) based on bed capacity:
  • 50-bed facility: INR 15-17 crores
  • 125-bed facility: INR 23-25 crores
  • 200-bed facility: INR 28-30 crores
  • The model is asset-light, focusing on operations rather than real estate acquisition.
  • Pre-operative costs include manpower and training, estimated at INR 1.25 crores for 50 beds, INR 2 crores for 125 beds, and INR 3-3.5 crores for 200 beds.
  • Future investments include rapid expansion in India and Africa, targeting 800-1,000 beds by 2028.
  • Expansion plans involve adding beds in Uganda, Navi Mumbai, Nashik, Tanzania, and East Africa, with potential for 600+ beds by FY27.

2 more points from Unihealth Hospitals Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Apollo Hospitals
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Unihealth Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided pages from the Unihealth Hospitals Limited conference transcript do not contain explicit information regarding the current or expected order book or pending orders. The discussion primarily focuses on bed capacities, operational milestones, revenue targets, occupancy rates, margins, and geographical expansion plans (India and Africa). If you need details about order book or pending orders specifically, they are not mentioned in the supplied sections of the document. Please provide a different page or section if available, or clarify if you want information on project pipelines or capacity expansion plans indirectly related to orders.

Others in Healthcare Services this season

  • Suven Life Sciences Ltd (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic Ltd (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnos.'s Q4 FY26 earnings…

  • KMC Speciality Hospitals (India) Ltd (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging and Path Lab Ltd (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Unihealth Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Unihealth Hospitals Ltd Q4 FY26 results?

Unihealth expects 30% to 40% growth in the coming quarters due to a low baseline currently. Target EBITDA margins expected around mid-20% by 24 months post facility commissioning (Page 23).

What is Unihealth Hospitals Ltd share price analysis?

Unihealth Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 41.9 with a market cap of ₹1,075 Cr. Investors should review the full earnings analysis for detailed insights.

Is Unihealth Hospitals Ltd planning capital expenditure?

Unihealth plans capital expenditure (Capex) based on bed capacity: - 50-bed facility: INR 15-17 crores - 125-bed facility: INR 23-25 crores - 200-bed facility: INR 28-30 crores - The model is asset-light, focusing on operations rather than real estate acquisition.

Keep Unihealth Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.